Teladoc Health Inc. (TDOC) experienced an after-hours plunge of 5.88% following the release of its first quarter 2026 financial results.
The company reported a quarterly loss per share of $0.36, which missed analyst estimates of a $0.33 loss. While quarterly revenue of $613.845 million slightly exceeded expectations, it represented a 2.47% decrease compared to the same period last year.
Investor sentiment was further impacted by the company's forward-looking guidance. Teladoc's outlook for the second quarter includes revenue projections of $597-626 million, with the midpoint below analyst estimates of $623.7 million. Additionally, the company's Q2 adjusted EBITDA guidance of $55-67 million fell short of the $68.5 million consensus estimate.